A Preview of the Dangerous Future of Abortion Bans — Texas Senate Bill 8
By Whitney Arey, Ph.D et al.,,
The New England Journal of Medicine
| 06. 22. 2022
Photo by Gayatri Malhotra on Unsplash
When the U.S. Supreme Court issues its decision in Dobbs v. Jackson Women’s Health Organization, the abortion care landscape will most likely be changed for at least a generation. Even before a draft opinion was leaked, many experts anticipated that the Court would overturn Roe v. Wade, and nearly half the states are poised to ban or dramatically limit abortion care when that occurs.1 These state laws criminalizing abortion may allow for very narrow exemptions, and anyone who violates the law could be subject to civil penalties, criminal fines, or imprisonment.2
Health systems and clinicians planning their responses3 can look to Texas, where we have already witnessed the impact of strict abortion bans on the provision of evidence-based, essential health care for pregnant people. Since September 1, 2021, Texas Senate Bill 8 (SB8) has prohibited abortions after the detection of embryonic cardiac activity, which occurs around 6 weeks after a person’s last menstrual period. After that point, SB8 allows abortions only in physician-documented medical emergencies. Anyone suspected of violating...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...